Showing results (711-720 of 851) with videos related to

Sort By:
Pageof 86
Foods (Basel, Switzerland)|January 11, 2024
An In-Depth Study on the Chemical Composition and Biological Effects of Pelargonium graveolens Essential OilMiroslava Kačániová, Milena Vukic, Nenad L Vukovic, et al.
The Science of the Total Environment|August 29, 2023
Blue carbon assessments of seagrass and mangrove ecosystems in South and Southeast Asia: Current progress and knowledge gapsMilica Stankovic, Amrit Kumar Mishra, Yusmiana P Rahayu, et al.
Oncotarget|December 22, 2016
Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancerPaul M Wilkerson, Konstantin J Dedes, Eleftherios Pierre Samartzis, et al.
Oxidative Medicine and Cellular Longevity|May 6, 2017
Dihydropyridine Derivatives as Cell Growth Modulators In VitroImanta Bruvere, Egils Bisenieks, Janis Poikans, et al.
American Journal of Public Health|June 22, 2018
Prevalence and Data Availability of Early Childhood Caries in 193 United Nations Countries, 2007-2017Maha El Tantawi, Morenike O Folayan, Mohamed Mehaina, et al.
Frontiers in Medicine|July 14, 2026
Organ-specific redox and trace element modulation and hematological adaptation following hyperbaric oxygenation and physical activity in ratsAleksandra Obradovic, Aleksandra Nenadovic, Nikola Mitovic, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 14, 2018
SOX3 can promote the malignant behavior of glioblastoma cellsJelena Marjanovic Vicentic, Danijela Drakulic, Idoia Garcia, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 2021
Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity SyndromesAfiya Andrews, Avinaash Maharaj, Emily Cottrell, et al.
Journal of Translational Medicine|December 6, 2019
Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational studyBenedetta M Motta, Christoph Grander, Martin Gögele, et al.
Therapeutic Advances in Medical Oncology|April 29, 2025
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancerPeter Schmid, Mafalda Oliveira, Joyce O'Shaughnessy, et al.
Pageof 86